OS Benefit to Adding Fulvestrant to First-Line Anastrozole in HR-Positive Metastatic Breast Cancer - Cancer Therapy Advisor

OS Benefit to Adding Fulvestrant to First-Line Anastrozole in HR-Positive Metastatic Breast Cancer  Cancer Therapy Advisor

The survival benefit of anastrozole/fulvestrant combination therapy was more pronounced in the subgroup of patients who did not have prior exposure to ...